What is OMER's P/E ratio?

OMEROS CORPORATION (OMER) currently trades at a P/E ratio of 5.16.

OMEROS CORPORATION reports a Return on Equity (ROE) of -136.06%.

What is OMER's dividend yield?

OMEROS CORPORATION offers a dividend yield of 0.00%.

What is OMER's Deepscope Quality Score?

Deepscope rates OMER's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy OMER?

Deepscope's AI Timing Score for OMER is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does OMER belong to?

OMEROS CORPORATION is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

หุ้น OMER (NASDAQ) | OMEROS CORPORATION – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-04 | FS: 2026-03-31)

OMER

OMEROS CORPORATION

US:NASDAQ STOCK Healthcare >> Biotechnology News 92

USD 10.25

0.09 (0.89%) Day Change

Watchlist Portfolio Compare Chart

5.16

P/E

-2.58

D/E

-136.1%

ROE

30.1%

ROA

0.00%

Div Yield

-0.04

PEG

OMEROS CORPORATION
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 10.25 Price 0.09 (0.89%) Day Change	NEWS SCORE: 92

OMER มีคุณภาพโดยรวมยังไม่ดีนัก ( คะแนนปัจจัยพื้นฐาน = 54) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตราผลตอบแทนผู้ถือหุ้น (ROE) ต่ำกว่าเกณฑ์
อัตราการเติบโตของอัตราผลตอบแทนผู้ถือหุ้น (ROE) ในปีก่อน เป็นลบ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ลดลงอย่างมีนัยยะสำคัญ
อัตราเร่งของการเติบโตของอัตราผลตอบแทนสินทรัพย์ (ROA) ต่ำกว่าเกณฑ์
อัตราเร่งของการเติบโตของอัตรากำไรสุทธิ ต่ำกว่าเกณฑ์

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ยังไม่ดีนัก สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร พอใช้ , ...

ปัจจัยทางคุณภาพ

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	92
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	10.25
PBV / Sector	-11.61 / 4.58
Earning Per Share	1.20

PE / Sector	5.16 / 17.10 GREAT
PEG or PE/Growth / Sector	-0.04 / 0.52
Average 1M Daily Value	21.10 M GREAT
Average 1W Daily Value	19.11 M GREAT

ปัจจัยทางเทคนิค

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	871.02 / 450.23 GREAT
NPM Average (%) / Sector	871.02 / -1,506.33 GREAT
NPM Change Average (%) / Sector	N/A / 4,941.30
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	30.11 / 30.58 GREAT
ROA Average (%) / Sector	-10.13 / -347.17
ROA Change Average (%) / Sector	-882.89 / 5,125.52
ROE (%) / Sector	-136.06 / -3.58
ROE Average (%) / Sector	95.90 / 40.65 GREAT
ROE Change Average (%) / Sector	-1,112.52 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.50
Dividend Change Average (%) / Sector	N/A / 5.02

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-05 09:11:55
Symbol	OMER
Name	OMEROS CORPORATION
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	72.38 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	735.33 / 8,655.90

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: The Omeros Building, Seattle, WA, United States, 98119

Phone: 206 676 5000

Website: https://www.omeros.com

Employees: 175

Sector: Healthcare >> Biotechnology

Description: Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-binding lectin-associated serine protease 2 (MASP-2) and lectin pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders, as well as cocaine use disorder. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; OncotoX-AML, to treat acute myeloid leukemia; and Targeted Complement Activating Therapy, for Multidrug-resistant organisms. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.